Study protocol for a randomised controlled trial of haloperidol plus promethazine plus chlorpromazine versus haloperidol plus promethazine for rapid tranquilisation for agitated psychiatric patients in the emergency setting (TREC-Lebanon)

F1000Research
Joseph E DibSouheil Hallit

Abstract

Background: Agitated and aggressive behaviours are common in the psychiatric setting and rapid tranquilisation is sometimes unavoidable. A survey of Lebanese practice has shown that an intramuscular haloperidol, promethazine and chlorpromazine combination is a preferred form of treatment but there are no randomised trials of this triple therapy. Methods: This is a pragmatic randomised trial. Setting - the psychiatric wards of the Psychiatric Hospital of the Cross, Jal Eddib, Lebanon. Participants - any adult patient in the hospital who displays an aggressive episode for whom rapid tranquilisation is unavoidable, who has not been randomised before, for whom there are no known contraindications. Randomisation - stratified (by ward) randomisation and concealed in closed opaque envelope by independent parties. Procedure - if the clinical situation arises requiring rapid tranquilisation, medical residents overseeing the patient will open a TREC-Lebanon envelope in which will be notification of which group of treatments should be preferred [Haloperidol + Promethazine + Chlorpromazine (HPC) or Haloperidol + Promethazine (HP)], along with forms for primary, secondary and serious adverse effects. Treatment is not given blindly. Outcome ...Continue Reading

References

Jun 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·L S PilowskyM Lader
Aug 1, 1985·The American Journal of Psychiatry·K Tardiff, H W Koenigsberg
Nov 1, 1994·The American Journal of Psychiatry·W A Fisher
Nov 7, 1998·BMJ : British Medical Journal·D G Altman
Sep 3, 1999·BMJ : British Medical Journal·P N van HartenR S Kahn
Jul 2, 2003·Emergency Medicine Journal : EMJ·A YildizA Turgay
Sep 16, 2003·Drugs of Today·Dawson HedgesPaul Whitehead
Jan 22, 2004·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Sabina Abidi, Sreenivasa M Bhaskara
Apr 23, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·P Lesage, R K Portenoy
Mar 5, 2005·Journal of Psychosocial Nursing and Mental Health Services·Janet Colaizzi
Apr 16, 2010·The Cochrane Database of Systematic Reviews·Uzair AhmedClive E Adams
Jan 9, 2013·Annals of Internal Medicine·An-Wen ChanDavid Moher
Oct 22, 2013·JAMA : the Journal of the American Medical Association·UNKNOWN World Medical Association
Nov 19, 2013·The Cochrane Database of Systematic Reviews·Clive E AdamsStephen Lawrie
Dec 19, 2013·BioMed Research International·C CantisaniS Calvieri
Jan 8, 2014·The Cochrane Database of Systematic Reviews·Clive E AdamsKarla Soares-Weiser
Mar 22, 2014·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Muaed Jamal Alomar
Jan 17, 2015·The Cochrane Database of Systematic Reviews·Markus DoldStefan Leucht
Feb 8, 2016·BMC Medical Ethics·Susanne RebersMarjanka K Schmidt
Nov 26, 2016·The Cochrane Database of Systematic Reviews·Gisele HufMichael H Allen
Dec 28, 2016·Journal of Clinical Psychopharmacology·Sean A RasmussenMichael F Mazurek
Sep 4, 2018·Medical Journal of the Islamic Republic of Iran·Joseph E DibSouheil Hallit

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Clinical Trials Mentioned

NCT03639558

Software Mentioned

SPSS
MS Access
SPIRIT
Statistical Package for Social Sciences ( SPSS )
MS Excel

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here